Scilex Holding (SCLXW) Invested Capital (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Invested Capital of -$173.3 million in Q1 2026, down 39.17% quarter-over-quarter from -$124.5 million in Q4 2025, and down 0.72% on a YoY basis from -$174.6 million in Q1 2025.

Scilex Holding (SCLXW) Invested Capital (2020 - 2026) Analysis & Trends

Scilex Holding's Invested Capital history runs 7 years deep, the most recent figure standing at -$173.3 million for Q1 2026.

  • In Q1 2026, Invested Capital fell 0.72% year-over-year to -$173.3 million; the TTM figure through Mar 2026 stood at -$173.3 million (down 0.72% YoY), while the FY2025 annual figure was -$124.5 million, up 21.07% from the prior year.
  • Invested Capital was -$173.3 million for Q1 2026 at Scilex Holding, down from -$124.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $36.2 million in Q4 2022 to a low of -$252.1 million in Q2 2022.
  • Historically, Invested Capital has averaged -$122.5 million across 5 years, with a median of -$131.3 million in 2025.
  • Biggest YoY gain for Invested Capital was 123.87% in 2022; the steepest drop was 2906.36% in 2022.
  • A 5-year view of Invested Capital shows it stood at $36.2 million in 2022, then sank by 278.01% to -$64.5 million in 2023, then slumped by 144.56% to -$157.8 million in 2024, then grew by 21.07% to -$124.5 million in 2025, then tumbled by 39.17% to -$173.3 million in 2026.
  • The last three Invested Capital figures came in at -$173.3 million (Q1 2026), -$124.5 million (Q4 2025), and -$131.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 72.79 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 98.65 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -6.66 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 48.32 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 66.51 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 45.69 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 90.96 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 64.21 Bn
10 Scilex Holding - - 4.15 Mn -173.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -173.29 Mn
Dec 31, 2025 -124.52 Mn
Sep 30, 2025 -131.26 Mn
Jun 30, 2025 -209.12 Mn
Mar 31, 2025 -172.04 Mn
Dec 31, 2024 -157.77 Mn
Sep 30, 2024 -126.68 Mn
Jun 30, 2024 -139.32 Mn
Mar 31, 2024 -96.86 Mn
Dec 31, 2023 -64.51 Mn
Sep 30, 2023 -47.45 Mn
Jun 30, 2023 26.33 Mn
Mar 31, 2023 11.08 Mn
Dec 31, 2022 36.24 Mn
Sep 30, 2022 -229.40 Mn
Jun 30, 2022 -252.10 Mn
Mar 31, 2022 -231.57 Mn
Dec 31, 2021 -151.84 Mn
Sep 30, 2021 -9.83 Mn
Jun 30, 2021 -8.39 Mn